期刊文献+

氟他胺与2-羟基氟他胺诱导正常大鼠前列腺细胞凋亡 被引量:1

Prostate apoptosis induced by flutamide and 2-hydroxyflutamide in normal rats
暂未订购
导出
摘要 目的 研究氟他胺及其活性代谢产物 2 羟基氟他胺诱导正常大鼠前列腺细胞凋亡的作用。方法 大鼠设正常组、去势组及给药组 ,比较前列腺各侧叶湿重 ,以HE染色及TUNEL染色法观察细胞凋亡并计算凋亡发生率。结果 氟他胺 10 0mg·kg-1及 2 羟基氟他胺 5 0mg·kg-1给药 7d可明显降低前列腺各侧叶湿重 ,并可观察到明显的凋亡细胞。结论 氟他胺与 2 羟基氟他胺可诱导正常大鼠前列腺细胞凋亡。 AIM To study the effect of flutamide (Flu) and 2 hydroxyflutamide (2 HF) inducing prostate apoptosis in normal rats METHODS Male Sprague Dawley rats were divided into intact, castrated, and medicated groups. The lobes of prostates were seperated and weighed The ventral lobes were used for HE stain and in situ labeling of fragmented DNA RESULTS The weight of lobes of prostates decreased significantly after rats were treated with Flu 100 mg·kg -1 or HF 50 mg·kg -1 , and there were obvious apoptotic cells in ventral lobes CONCLUSION Flu and HF can induce prostate apoptosis in normal rats
出处 《中国药理学通报》 CAS CSCD 北大核心 2000年第3期290-292,共3页 Chinese Pharmacological Bulletin
关键词 氟他胺 羟基氟他胺 前列腺癌 细胞凋亡 flutamide 2 hydroxyflutamide prostate apoptosis
  • 相关文献

参考文献4

二级参考文献20

  • 1张宏伟,李端.非甾体类抗雄激素药氟他胺的研究概况[J].中国药理学通报,1996,12(6):484-486. 被引量:3
  • 2Huang W Y,中国药理学报,1989年,10卷,461页
  • 3李端,新药与临床,1987年,6卷,102页
  • 4Schwartz JI,Laskin OL,Meeter CA,et al.Pharmacodynamics of MK-0963,a new 5α-reductase inhibitor:Effect on scrum androgen concentrations. Clinical Pharmacology and Therapeutics . 1994
  • 5Lepor H,Tang R,Shapiro E,et al.Location of the alphak adrenoceptor subtypes in the human prostate. Journal d Urologie . 1994
  • 6Kobayashi S,Tang R,Shapiro E,et al.1</sub>,adrenoceptor binding sites using radioligand receptor binding on slide-mounted tissue sections&amp;sid=Journal d Urologie&amp;aufirst=Kobayashi S');&#xA; ">Characterization of human alpha<sub>1</sub>,adrenoceptor binding sites using radioligand receptor binding on slide-mounted tissue sections. Journal d Urologie . 1993
  • 7Gormley GJ.Finasteride:a clinical review. Biomedicine and Pharmacotherapy . 1995
  • 8Fitzpatrick JM,Lynch TH.Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia. Urologic Clinics of North America . 1995
  • 9Depre M,Meeter MA,Van Hecken A,et al.Pharmacodynamics and tolerability of L-654,066,a steroid 5α-reductase,inhibitor,in men. Clinical Pharmacology and Therapeutics . 1992
  • 10Audet PR,Baine BH,Benincosa LJ,et al.Epristeride. Drugs of the Future . 1994

共引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部